Skip To Main Content
Barbara A. Cohn on Muck Rack

Barbara A. Cohn

Berkeley
As seen in: Environmental Health Perspectives, Nature, Wiley Online Library, CNBC, TechCrunch, MDPI, Science Magazine, Pediatrics, Cancer Epidemiology, Biomarkers & Prevention, Endocrine Today and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Barbara A.

Contact Barbara A., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Grandmaternal perinatal serum polychlorinated biphenyls and prevalence of obesity in adult daughters and granddaughters

|
By Barbara A. Cohn, Piera M. Cirillo, Caitlin Murphy, Xin Hu
| Wiley Online Library Verified
What is already known? Noncoplanar polychlorinated biphenyl (PCB) 138, PCB 153, and PCB 180 independently increase lipids stored in adipocytes through distinct mechanisms, and their enzyme induction profiles, nuclear receptor activation, and signaling pathways are congener-specific. Fetal life is a window of susceptibility to environmental obesogens, with consequences for obesity over the life course. What does this study add?
Open in Who Shared Issue with article?

387. Prenatal Maternal Inflammation is Associated With Offspring Sensory Gating in Late Midlife

|
By Madeline Pike, Elizabeth Breen, Barbara A. Cohn, Seth Brayton
| Biological Psychiatry Verified
Although sensory gating (SG; ability to filter irrelevant input) naturally declines with age, accelerated SG deficits are a transdiagnostic risk factor for psychopathology. Animal studies suggest these deficits originate in-utero, with prenatal maternal inflammation (PNMI) increasing the risk of neurodevelopmental disorders, particularly in females.
Open in Who Shared Issue with article?

"In Utero Exposure to 17α-Hydroxyprogesterone Caproate and Risk of Canc" by Caitlin C Murphy, Piera M Cirillo et al.

|
By Caitlin Murphy, Piera M. Cirillo, Nickilou Y. Krigbaum, Barbara A. Cohn
| Texas Medical Center
BACKGROUND: 17α-hydroxyprogesterone caproate is a synthetic progestogen initially approved in the 1950s to treat gynecologic and obstetrical conditions. Despite continued concerns about safety and short-term efficacy regarding the use of 17α-hydroxyprogesterone caproate for the prevention of preterm birth in pregnant women, little is known about the long-term effects of 17α-hydroxyprogesterone caproate on the health of the offsprings.
Open in Who Shared Issue with article?
See all 18 licensed articles (20 Total)